Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 200,158 | 42,189 | 0 | N/A |
| Marketable Securities | 17,197 | N/A | 0 | N/A |
| TOTAL | $221,355 | $42,937 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,762 | 1,511 | 0 | N/A |
| Other Non-Current Assets | 101 | 100 | 0 | 0 |
| TOTAL | $1,863 | $1,611 | $N/A | $N/A |
| Total Assets | $223,218 | $44,548 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,219 | 1,863 | 0 | 0 |
| Accrued Expenses | 3,239 | 1,749 | 0 | N/A |
| Other current liabilities | 170 | 161 | 0 | N/A |
| TOTAL | $52,780 | $3,773 | $0 | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 48,152 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 180 | 349 | 0 | 0 |
| TOTAL | $3,080 | $349 | $N/A | $N/A |
| Total Liabilities | $55,860 | $4,122 | $0 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 619 | N/A | N/A | N/A |
| Common Shares | 31 | 2 | 0 | N/A |
| Retained earnings | -68,888 | -49,088 | 0 | N/A |
| Other shareholders' equity | 54 | 88,708 | 0 | 0 |
| TOTAL | $167,358 | $40,426 | $0 | $N/A |
| Total Liabilities And Equity | $223,218 | $44,548 | $0 | $0 |